期刊文献+

黄体酮阴道缓释凝胶的处方及工艺的研究 被引量:4

Study on Formulation and Preparation Technology of Progesterone Vaginal Sustained-release Gel
下载PDF
导出
摘要 制备黄体酮阴道缓释凝胶,以处方的外观性状、流变学和体外溶出为评价标准,采用单因素实验优化处方的制备工艺。以自制制剂与市售制剂Crinone体外溶出曲线的相似因子作为主要评价指标,使用单因素法考察处方因素对黄体酮阴道缓释凝胶的体外溶出的影响。结果表明,甘油、粒径以及聚卡波非与粒径的交互作用显著影响黄体酮缓释凝胶的体外释放。最优处方与市售制剂相似因子f2=64.23,外观性状及流变学等行为也相似,为后期体内研究奠定了基础。 Progesterone vaginal sustained-release gelwas prepared,taking the appearance properties,rheology and in vitro dissolution of the preparations as the evaluation criteria,the preparation process of the gel by using single factor experimentswas optimized.Single factor method was used to investigate the factors affectingin vitro dissolution of the progesterone vaginal sustained-release gel.The similar factors ofin vitro dissolution curves of self-made preparations and commercial preparations Crinone were used as the main evaluation indicators.The result showed thatglycerin,particle size and the interaction of polycarbophil and particle size significantly affected in vitro release of progesterone sustained-release gel.The similar factor of optimal preparation was 64.23 and theappearance and rheology results were relatively close,laying the foundation for later in vivo studies.
作者 吴雪青 余倩 林霞 杨子毅 WU Xue-qing;YU Qian;LIN Xia;YANG Zi-yi(College of Pharmacy,Jiangnan University,Wuxi Jiangsu 214122,China)
机构地区 江南大学药学院
出处 《广州化工》 CAS 2021年第17期110-114,共5页 GuangZhou Chemical Industry
基金 国家自然科学基金(81603060) 江苏高校品牌专业建设工程项(PPZY2015B146)。
关键词 黄体酮 阴道制剂 体外溶出 单因素法 progesterone vaginalformulation in vitro release signalfactor experiment
  • 相关文献

参考文献3

二级参考文献45

  • 1徐晖 李英剑 严志 等.黄体酮缓释凝胶的体外释放性质研究[EB/OL].http://www.pharmj.cn,2003-05.
  • 2Valenta C,Kast EC,Harich I,et al.Development and in vitro evaluation of mucoadhesive vaginal delivery system for progesterone[J].J Controlled Release,2001,77(3)∶323-332.
  • 3Mandal TK.Swelling-controlled release system for the vaginal delivery of miconazole[J].Eur J Pharm Biopharm,2000,50∶337-343.
  • 4Robinson JR,Bologna WJ.Vaginal and reproductive system treatment using a bioadhesive polymer[J].J Controlled Release,1994,28(1)∶87-94.
  • 5Haigh JM,Beyssac E,Chanet L,et al.In vitro permeation of progesterone from a gel through the shed skin of three different snake species[J].Int J Pharm,1998,170∶151-156.
  • 6Devoto L, Fuentes A, Kohen P, et al. The human corpus luteum: life cycle and function in natural cycles. Fertil Steril, 2009, 92(3): 1067-79.
  • 7Chabbert Buffet N, Djakoure C, Maitre SC, et ai. Regulation of the human menstrual cycle, Front Neuroendocrinol, 1998, 19(3):151-86.
  • 8Szekeres-Bartho J, Wilczynski JR, Basta P, et al. Role of progesterone and progestin therapy in threatened abortion and preterm labour. Front Biosci, 2008, 13:1981-90.
  • 9Csapo AI, Pulkkinen MO, Wiest WG. Effects of lutectomy and progestreone replacement therapy in early pregnancy patients. Am J Obstet Gynecol, 1973, 115(6):759-65.
  • 10Messinis I, Messini C, Dafopoulos K. Luteal-phase endocrinology. Reprod Biomed Online, 2009, 19(4):4314.

共引文献179

同被引文献38

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部